| 1 |
A High-Affinity Monoclonal Antibody to Anthrax Protective Antigen Passively Protects Rabbits before and after Aerosolized Bacillus anthracis Spore Challenge
Nehal Mohamed, Michelle Clagett, Juan Li et al. · Infection and Immunity
Open access |
20 Jan 2005 |
124 |
| 2 |
Enhancement of Anthrax Lethal Toxin Cytotoxicity: a Subset of Monoclonal Antibodies against Protective Antigen Increases Lethal Toxin-Mediated Killing of Murine Macrophages
Nehal Mohamed, Juan Li, Cláudia S. Ferreira et al. · Infection and Immunity
Open access |
20 May 2004 |
62 |
| 3 |
Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax
Brent Yamamoto, Annette M. Shadiack, Sarah Carpenter et al. · Antimicrobial Agents and Chemotherapy
Open access |
19 Jul 2016 |
49 |
| 4 |
Inhaled vs subcutaneous effects of a dual IL‐4/IL‐13 antagonist in a monkey model of asthma
Adrian Tomkinson, Jeffrey S. Tepper, Matthew T. Morton et al. · Allergy
|
Oct 2009 |
46 |
| 5 |
Selective and efficient inhibition of the alternative pathway of complement by a mAb that recognizes C3b/iC3b
David J. DiLillo, Andrew W. Pawluczkowycz, Peng Wu et al. · Molecular Immunology
|
15 Jun 2005 |
38 |
| 6 |
Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity
Brent Yamamoto, Annette M. Shadiack, Sarah Carpenter et al. · Antimicrobial Agents and Chemotherapy
Open access |
19 Jul 2016 |
35 |
| 7 |
A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1)
Alexander Repik, Steve E. Pincus, Ionita Calin Ghiran et al. · Clinical & Experimental Immunology
Open access |
11 Mar 2005 |
30 |
| 8 |
Animal‐to‐Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule
CF Nagy, John T. Mondick, Natalya V. Serbina et al. · Clinical and Translational Science
Open access |
7 Dec 2016 |
25 |
| 9 |
Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans
Christa F. Nagy, Timothy S. Leach, Alex King et al. · Clinical Pharmacology in Drug Development
Open access |
10 Nov 2017 |
22 |
| 10 |
Pharmacokinetics and Tolerability of Obiltoxaximab: A Report of 5 Healthy Volunteer Studies
Christa F. Nagy, Timothy S. Leach, Joseph H. Hoffman et al. · Clinical Therapeutics
Open access |
30 Aug 2016 |
22 |
| 11 |
A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation
Peng Wu, Xin Zhang, Nehal Mohamed et al. · Cancer Immunology Immunotherapy
Open access |
21 Apr 2005 |
20 |
| 12 |
Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen
Lisa N. Henning, Sarah Carpenter, Gregory V. Stark et al. · Antimicrobial Agents and Chemotherapy
Open access |
13 Nov 2017 |
19 |
| 13 |
First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer ETI-104
Christof Iking‐Konert, Susan Jill Stocks, Frank Weinsberg et al. · Annals of the Rheumatic Diseases
Open access |
12 Aug 2004 |
18 |
| 14 |
Development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting Clostridioides difficile toxins in clinically relevant stools samples
Arik Elfassy, Warren V. Kalina, R. C. French et al. · Anaerobe
|
20 Jul 2021 |
12 |
| 15 |
Heteropolymers: a novel technology against blood-borne infections.
Nehal Mohamed, Steven M Jones, Leslie S. Casey et al. · PubMed
|
Apr 2005 |
12 |
| 16 |
Evaluation of Antigen-Based Heteropolymer for Treatment of Systemic Lupus Erythematosus in a Nonhuman Primate Model
Steve E. Pincus · Clinical Immunology
|
Nov 2002 |
8 |
| 17 |
Purification of antibody heteropolymers using hydrophobic interaction chromatography
И. О. Костарева, Finn Hung, Colin William Barr Campbell · Journal of Chromatography A
|
6 Nov 2007 |
6 |
| 18 |
Treatment with an Anti-C3b/iC3b Monoclonal Antibody as an Adjuvant to Rituximab Enhances the Killing of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia Cells.
Peng Wu, Xin Zhang, Juan Li et al. · Blood
|
16 Nov 2004 |
1 |
| 19 |
Therapeutic Potential of Cells of the Immune System
Lawrence S. Lamb, William Ho · Elsevier eBooks
Book chapter |
2020 |
0 |
| 20 |
A novel dual antibody conjugate (Heteropolymer) reduces circulating HIV in a mouse model
S. H. Pincus, SM Jones, TA Bradley et al. · Retrovirology
Open access |
Dec 2006 |
0 |